Somatoform Disorders: Symptoms, Types, and Treatment

What is Somatic Symptom Disorder?

Somatic symptom disorder is a psychological condition characterized by a persistent preoccupation with physical symptoms, such as pain, weakness, or shortness of breath, that causes significant distress and impairment in daily functioning.

SSD is diagnosed when a person has excessive thoughts, feelings, and behaviors about their physical symptoms. This often leads to frequent doctor visits and medical tests.

Somatic symptom disorder is a diagnosis introduced in the DSM-5, the American Psychiatric Association’s 2013 diagnostic manual. It absorbed most of the older somatoform diagnoses, including somatization disorder and hypochondriasis.

Types of Somatoform Disorders

Somatic symptom disorder (SSD) replaced most of the somatoform disorders. These older diagnoses covered conditions in which thoughts, actions, and emotions correlate with somatic symptoms.

The previous edition, DSM-IV, listed four main somatoform diagnoses. DSM-5 folded most of them into SSD:

• Somatization disorder: Most cases now fall under SSD.
• Hypochondriasis: Most cases now fall under SSD, while those with high health anxiety but few or no symptoms fall under illness anxiety disorder.
• Pain disorder: Now diagnosed as SSD with predominant pain.
• Undifferentiated somatoform disorder: Also largely absorbed into SSD.

DSM-5 keeps conversion disorder, also called functional neurological symptom disorder, as a separate diagnosis, and adds illness anxiety disorder. It also places factitious disorder in the same family, along with residual categories for other specified and unspecified somatic symptom disorders.

Factitious disorder and malingering differ from all of these. Their symptoms are deliberately produced or feigned, whereas the symptoms and distress in SSD are genuinely experienced.

Oftentimes patients have disproportionate amounts of anxiety correlated to their physical symptoms.

The symptoms may or may not be linked to an underlying medical condition. Either way, the distress is real. Excessive worry can convince people that they are seriously ill.

These patients frequently seek care and continue to search for an explanation for their symptoms even when other serious conditions have been excluded.

Risk Factors

Factors that make a person more at risk of having somatic symptom disorder include:

• Previous history of anxiety and depression
• Having a medical condition, recovering from one, or having a strong family history of a medical condition
• Stressful life experiences, such as trauma, violence, child abuse, sexual abuse, etc
• Poor socioeconomic status and low education level

Prevalence and Course

Estimates vary with how researchers measure the disorder. Around 7% of adults are affected in general terms.

DSM-5-TR, the 2022 text revision of the manual, puts the general-population figure nearer 4% to 6% in North American and European samples.

Rates climb where symptoms concentrate. They reach 10% to 20% in primary care and 40% to 60% in clinics specializing in psychosomatic or functional disorders (American Psychiatric Association, 2022).

Questionnaire studies report a pooled frequency of about 12.9% (Löwe et al., 2021). That figure probably overstates the diagnosis, because a brief questionnaire cannot confirm that the response is truly excessive.

SSD is more common in women than in men. Multiple adverse childhood experiences raise somatic symptoms in both sexes, but more strongly in women (American Psychiatric Association, 2022).

There is no evidence that gender affects how well people respond to treatment.

The course is usually chronic and fluctuating. The dominant symptom may change, but the distress often persists for years.

SSD co-occurs strongly with anxiety and depression, and it brings reduced quality of life and heavy health-care use (Löwe et al., 2021).

Symptoms

Pain is the most commonly reported symptom. The specific symptom often changes over time, while the overall state persists.

The signature of SSD is worry that persists after medical reassurance. In most conditions, a normal test result is reassuring. In SSD, it reassures only briefly. The anxiety soon returns, sometimes reframed as a belief that the test missed something.

Assessment is therefore clinical rather than a diagnosis of exclusion. Clinicians look for disproportionate thinking and behavior, using the person’s history and brief self-report questionnaires that measure the psychological component.

Causes of Somatic Symptom Disorder

Contemporary accounts of SSD are mostly cognitive-behavioral. They start from a simple idea.

The brain does not receive bodily sensations passively; it attends to them, interprets them, and acts on them. In SSD, each step is biased in a way that amplifies symptoms.

Somatosensory Amplification

Some people experience bodily sensations as unusually intense. This is called somatosensory amplification. It makes sensations feel noxious and disturbing.

A benign sensation can feel mild to one person and alarming to another.

Barsky and Wyshak (1990) tested the idea in 177 medical outpatients. Amplification correlated strongly with hypochondriasis, the preoccupation with having an illness (r = .56). The link held up. After sociodemographic factors were controlled, amplification still accounted for about 31% of the variance.

Adding fears of ageing and death, and a childhood history of family illness, raised this to about 50%. Amplification was stronger in women and correlated more weakly with somatization.

Caution is needed, though. The study was cross-sectional, so it cannot show that amplification causes the preoccupation.

Attention, Interpretation, and Expectation

Amplification is one strand of a wider model. Rief and Broadbent (2007) reviewed experimental, clinical, and neuroimaging research on how people perceive and explain persistent bodily symptoms. They identified four recurring biases:

• Misinterpretation: People read benign sensations as signs of serious disease.
• Over-exclusive health concept: They believe a healthy person should have no symptoms at all.
• Selective attention: Attention and memory keep the body under constant surveillance.
• Expectation: Expecting a symptom activates the same sensory brain regions as the symptom itself, and distraction reduces that activity.

So anticipating a symptom can help produce it. Reassurance often fails because conversations with doctors are filtered through these same biases.

Each bias is also a treatment target, which is why cognitive-behavioral therapy works on them directly.

Mentalizing Difficulties

A newer line of research asks whether these biases are compounded by something more basic. Mentalizing is the capacity to understand your own and other people’s mental states, such as thoughts, feelings, and intentions, as the explanation for behavior.

Kocsis-Bogar et al. (2026) searched ten databases and found ten case-control studies of 314 patients with SSD. Nine were meta-analyzed. Patients showed poorer mentalizing than non-clinical controls, including about other people’s thoughts and feelings.

But the difference disappeared against people with depression or post-traumatic stress disorder. Most studies also carried a high risk of bias.

Reduced mentalizing may therefore be shared across disorders rather than specific to SSD. It may share a common root with the biases above. The authors call for better-powered, diagnosis-specific studies.

A Self-Sustaining Loop

Wider risk factors map onto this machinery.

Predisposing factors include a temperamental sensitivity to bodily sensation, earlier anxiety or depression, and an illness history that teaches vigilance about the body.

Precipitating factors include acute stress, trauma, violence, and childhood adversity such as physical or sexual abuse. Perpetuating factors include reassurance-seeking and body checking. These bring brief relief but stop the person from testing their catastrophic beliefs.

Repeated medical tests can backfire too. This problem is called iatrogenic, meaning caused by medical care itself. Testing can confirm to the patient that something serious is being sought.

The result is a loop. A sensation is amplified, filtered through catastrophic thinking, watched closely, and checked. Checking and doctor visits ease anxiety briefly, which reinforces them. The underlying beliefs never change.

Treatment Options

The main aim of treatment is to enhance a person’s daily functioning by reducing their physical symptoms or improving their ability to cope. Psychological therapy, mainly CBT, is the mainstay. Medication mainly treats co-occurring depression and anxiety, and hypnosis may help with pain.

If left untreated, somatic symptom disorder can lead to poor health, problems functioning in daily life, physical disability, relationship problems, work problems, and unemployment.

Other complications include co-occurring mental health disorders, such as anxiety, depression, and personality disorders. SSD is also independently associated with suicidal thoughts and attempts. Part of this link reflects overlap with depression, but the severity of the physical symptoms adds its own risk (American Psychiatric Association, 2022).

These individuals also face financial problems due to recurrent healthcare visits and excessive medication usage.

Medication

In case of a co-occurring condition, such as anxiety or depression, antidepressant medications may be used.

These medications alone cannot resolve somatic symptoms, but they help alleviate the symptoms of associated co-occurring conditions, particularly when combined with psychotherapy.

Easing mood and anxiety symptoms can reduce the emotional burden that fuels symptom preoccupation. Prescribing needs care, though. People with SSD are often sensitive to medication and watchful for side effects.

Psychotherapy

Cognitive-behavioral therapy (CBT) is the most commonly used treatment option focused on helping people better manage their thoughts and behaviors.

CBT targets the thinking and behavior that keep the disorder going. It re-examines catastrophic readings of bodily sensations. It also loosens the belief that a healthy person should feel no symptoms at all.

CBT also cuts back symptom checking and reassurance-seeking. These give brief relief, but they stop beliefs from being tested. People can then decrease their preoccupation with symptoms and engage more fully in daily life.

A Cochrane review pooled 21 randomized trials with 2,658 participants (van Dessel et al., 2014). Fourteen trials tested forms of CBT.

Psychological therapy reduced symptom severity more than usual care or waiting lists, with a small-to-medium effect. Benefits lasted beyond one year.

But CBT was not clearly better than well-structured medical care, and the quality of evidence was low to moderate. Trials also enrolled only patients willing to accept a psychological approach.

Internet-Delivered CBT

Face-to-face CBT is limited by therapist availability, cost, and geography. Online delivery widens access.

Liu et al. (2026) meta-analyzed 23 randomized trials of internet-delivered CBT, with 1,746 participants in treatment groups and 1,553 in control groups. Somatic symptoms and health anxiety were the main outcomes.

Internet CBT matched other face-to-face psychotherapies on general symptoms and health anxiety. It beat waiting-list controls on most outcomes, with effects up to g = 0.71 for health anxiety. It was comparable to, or slightly better than, treatment as usual for several symptom clusters.

About 27% of participants reported an adverse event. None was serious. Effects varied by symptom subtype and comparator, which points toward more personalized digital protocols.

Hypnosis

Hypnosis is a systematic procedure conducted by a trained psychotherapist during which a person, responding to suggestions, experiences changes in memory, perception, and/or voluntary action.

Pain is the most common symptom of SSD. Treatments that target pain are therefore clinically relevant. A meta-analysis of 85 controlled trials with 3,632 participants found that hypnosis gave moderate pain relief (Thompson et al., 2019).

The benefit depended on hypnotic suggestibility, a person’s capacity to respond to hypnotic suggestion. Highly and moderately suggestible participants reduced pain by about 42% and 29%. Those low in suggestibility gained little.

One caution applies. Most trials used experimentally induced pain in healthy volunteers. Whether hypnosis helps the chronic clinical pain seen in SSD still needs better clinical trials.

Stepped Care and the Therapeutic Alliance

Across all treatments, a strong therapeutic alliance and sustained engagement are decisive. The alliance is the collaborative working relationship between clinician and patient. It matters especially because people convinced their problem is purely physical may resist a psychological framing.

Guidelines favor stepped care (Henningsen, 2018; Kurlansik & Maffei, 2016). It is a biopsychosocial approach, which treats biological, psychological, and social factors as jointly relevant.

Primary care, a somatic specialist, and mental health services cooperate, and treatment intensity matches symptom severity. Symptoms are taken seriously without being over-investigated. Practical principles include:

• Single coordinator: One clinician coordinates care.
• Scheduled visits: Regular appointments replace symptom-triggered ones, which reward symptom escalation.
• Fewer tests: Unnecessary investigations are limited.
• New goal: The aim shifts from finding the cause to improving function and coping.

Patient Perspectives on Uncertainty

Two patient accounts show why this matters.

As Hannah Vickers describes, her persistent pain had no clear explanation despite investigations. Her turning point was not a diagnosis.

It was reframing her relationship to the pain. She moved from searching for a cause to accepting uncertainty and rebuilding function (Vickers, 2020).

Mark Wong tells a complementary story. Writing about his own medically unexplained symptoms, he argues that what helped was a clinician who admitted uncertainty honestly. Hearing that the doctor did not know was more containing than repeated tests and hollow reassurance (Wong, 2020).

Both accounts fit the finding that reassurance fails when it is filtered through cognitive biases (Rief & Broadbent, 2007). The practical stance that follows is simple. Validate the symptom, be honest about diagnostic uncertainty, and shift the shared goal from cure to coping.

SSD vs. Illness Anxiety Disorder

Illness anxiety disorder (IAD) is a preoccupation with having or acquiring a serious illness, with few or no somatic symptoms (French & Hameed, 2021). It covers the minority of former hypochondriasis cases with high health anxiety but little physical symptom. Most other former cases now fall under SSD.

In contrast, SSD is characterized by at least one specific somatic symptom causing significant disruption in one’s life.

IAD is the focus on an illness, while SSD is the focus on a specific symptom.

The DSM-5 describes two subtypes of illness anxiety disorder, care-seeking and care-avoidant. Real life is more fluid.

Kikas et al. (2026) interviewed 37 people who met the criteria for IAD. Help-seeking was driven by internal factors, including symptoms, worry, and wanting to stay healthy for their children. External factors included cost and a busy lifestyle.

Negative past experiences with health professionals often made people avoid care. Emotional fatigue from repeated care-seeking could also tip seeking into avoidance.

A third pattern, care-fluctuating, fits these accounts. A clinician who assesses only the current presentation could miss it.

Both SSD and IAD involve preoccupation with a medical illness. In SSD, though, the complaint has a somatic expression. IAD is dominated by anxiety about acquiring a serious medical illness.

Both cases are characterized by frequent doctor visits and increased worry and anxiety due to failure to diagnose.

SSD vs. Conversion Disorder

Conversion disorder is also known as functional neurological symptom disorder. Patients have involuntary neurological symptoms, such as paralysis or sensory loss, that do not fit any recognized neurological disease.

Non-epileptic seizures are one example. The person shows convulsions or jerking that resemble a seizure, yet there is no abnormal EEG activity.

The term conversion disorder was developed by Sigmund Freud, who believed that neurological symptoms arise from repressed psychological conflict.

In conversion disorder, loss or alteration of neurological function dominates. Diagnosis rests on positive signs that the symptoms are incongruent with recognized neurological disease (Hurwitz, 2004).

SSD works differently. The impairment arises mainly from the excessive emotional and cognitive response to symptoms. Patients usually catastrophize the symptoms, and much of the disruption to daily functioning comes from the emotional consequences.

Critical Evaluation of the SSD Diagnosis

The DSM-5 reform divides experts. Supporters say it fixed a flawed diagnosis. Critics say it risks labeling ill people as mentally disordered. The evidence backs the reform in part, with caveats.

Expert Views on the Reform

As Joel Dimsdale explains, the old requirement for symptoms to be medically unexplained caused three problems. Dimsdale chaired the DSM-5 work group on somatic symptom disorders.

His group judged the requirement unreliable, because clinicians disagreed on whether a symptom had an organic cause. It forced a mind-body split. It also stigmatized patients, who heard the word unexplained as unreal (Dimsdale et al., 2013).

Dimsdale argues that the reform is more humane.

It defines the disorder by disproportionate thoughts, anxiety, and behavior. That validates the patient’s suffering whether or not the symptoms have an organic cause.

Allen Frances, who chaired the earlier DSM-IV task force, is the most prominent critic. His commentary is widely cited (Frances, 2013).

He warns that SSD is too inclusive. The criteria allow the diagnosis even when symptoms are medically explained. They also rest on the loosely defined word excessive.

That risks labeling people coping with serious illness as mentally ill, such as cancer patients worried about their cancer.

Frances adds that the DSM-5 field trials implied worrying rates of false-positive diagnosis, meaning people wrongly labeled as disordered. He argues that the reform traded one problem for another.

The disagreement is not merely rhetorical. It maps onto a weakness the research also names: the psychological criterion needs tighter specification (Löwe et al., 2021).

Cultural Framing

Culture shapes how bodily distress is expressed. Studies worldwide find a broadly similar pattern of common symptoms, impairment, and treatment-seeking. But the specific symptoms people report, and the meanings they attach to them, differ by culture (American Psychiatric Association, 2022).

These culturally shaped presentations are called idioms of distress. Complaints of bodily heaviness or excess heat are common in some cultures and rare in others.

In China, shenjing shuairuo means weakness of the nerves. It links fatigue and low energy to an imbalance of hot and cold. Such models attribute bodily distress to a different cause than a Western biomedical framework would.

Depression, too, often shows up as bodily complaints in many cultures. The boundary is not culture-free. A clinician’s own idiom shapes what looks excessive and what looks like ordinary illness talk.

DSM-5 vs. ICD-11

The World Health Organization’s ICD-11 (the eleventh International Classification of Diseases) offers a rival construct, bodily distress disorder (BDD).

Gureje and Reed (2016) describe how the two systems compare. Both drop the medically unexplained requirement.

They differ in emphasis. ICD-11 foregrounds the bodily symptoms and the excessive attention paid to them, graded by severity, and it was designed for primary care worldwide. DSM-5 gives more weight to catastrophic thoughts and health anxiety. Confusingly, BDD also abbreviates body dysmorphic disorder.

Schumacher et al. (2017) compared the two systems, plus a third proposal called polysymptomatic distress disorder, in 321 people from the German general population.

They followed participants for one and four years. All three predicted future impairment and symptom count about equally well. The ICD-11 criteria predicted future health-care use best, with a large effect against medium effects for SSD.

No scheme was clearly superior on every outcome, so the question remains open.

Contemporary Research

Two questions organize recent research. Is the diagnosis valid, and does treatment work? Stronger study designs deserve more weight in answering both.

Is the Diagnosis Valid?

Löwe et al. (2021) ran a scoping review of research published since SSD was introduced. It covered PubMed, PsycINFO, and the Cochrane Library from 2009 to 2020. The team synthesized 59 full texts out of 882 articles.

The evidence supported the reliability, validity, and clinical utility of the SSD criteria. They improved on their predecessors. SSD identifies people who are markedly impaired both physically and psychologically.

However, the psychological criterion needs tighter specification, and no prevalence studies have used gold-standard diagnostic interviews. The reform met its core aim. The loose threshold for excessive remains its weakest seam.

How Well Does Treatment Work?

Leaviss et al. (2020) ran a network meta-analysis, a method that compares many treatments in one analysis. It pooled 59 randomized trials with 9,077 patients and covered behavioral treatments for medically unexplained symptoms in primary care.

Several treatments beat usual care on specific outcomes. High-intensity CBT improved pain, anxiety, and depression. Low-intensity CBT and relaxation or support helped fatigue. Multimodal therapy improved physical functioning.

No single treatment worked across all symptoms. General-practitioner-led interventions showed no significant benefit, few effects lasted to long-term follow-up, and none convincingly reduced overall symptom burden. The networks were sparse and results varied widely between studies.

Berezowski et al. (2022) asked if early treatment helps more. They pooled 30 randomized trials of early psychological interventions, from bibliotherapy (therapeutic reading) to full CBT. Participants were at risk or had mild or new symptoms.

Early treatment produced small effects on somatic symptom severity (g = 0.25) and health-care use (g = 0.31). Caution is needed because of a high risk of bias.

The ceiling is similar across all three syntheses. Effects are small when treatment starts early (Berezowski et al., 2022).

They are small to medium in established cases (van Dessel et al., 2014; Leaviss et al., 2020). One reading is that the limit lies in the maintaining mechanisms of the disorder, not the timing of treatment.

Further Information

• Dimsdale, J. E., Creed, F., Escobar, J., Sharpe, M., Wulsin, L., Barsky, A., … & Levenson, J. (2013). Somatic symptom disorder: an important change in DSM. Journal of psychosomatic research, 75(3), 223-228.
• Katz, J., Rosenbloom, B. N., & Fashler, S. (2015). Chronic pain, psychopathology, and DSM-5 somatic symptom disorder. The Canadian Journal of Psychiatry, 60(4), 160-167.
• Kurlansik, S. L., & Maffei, M. S. (2016). Somatic symptom disorder. American family physician, 93(1), 49-54.